Clinical Trial

Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-07-30; most recent amendment 2024-08-27.
Status change: Recruiting → Active, Not Recruiting 2024-08-27
Trial Details
NCT Number NCT04993638
Lead Sponsor EUROS
Conditions Hip Arthropathy, Hip Osteoarthritis, Hip Arthritis, Hip Fractures, Hip Necrosis, Hip Dysplasia
Enrollment 147 participants
Start Date 2021-06-01
Primary Completion 2034-06-01 (estimated)
Study Completion 2034-06 (estimated)
Updated on ClinicalTrials.gov 2024-08-28